Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
31 Jul 2024
Quarterly Activities/Appendix 4C Cash Flow Report
25 Jul 2024
Sustained Reduction in Tumour Size Seen In Pancreatic Trial
22 Jul 2024
Proposed issue of securities - ATX
22 Jul 2024
Notice of Annual General Meeting/Proxy Form
19 Jul 2024
Section 708A Cleansing Notice
19 Jul 2024
Application for quotation of securities - ATX
17 Jul 2024
Proposed issue of securities - ATX
17 Jul 2024
Application for quotation of securities - ATX
12 Jul 2024
Bioshares Conference Presentation
03 Jul 2024
First 26 Patients recruited in Phase 2A ACCENT Trial
Previous
1
2
3
4
5
6
Next
